Skip to main content

Thiogenesis Therapeutics Corp(TTI-X)
TSX Venture

Today's Change
Delayed Last Update

Thiogenesis Therapeutics Corp

4 King Street West
Suite 401
Toronto ON M5H 1B6 CAN
P: 647-846-7766
https://www.thiogenesis.com

Sectors & Indices

Sector
Industry
Employees

Profile

Thiogenesis Therapeutics Corp is a clinical-stage biotech company. The Company is developing thiol-active therapeutic compounds, that are prodrugs, used to treat unmet pediatric medical needs. TTI-0102, the Company's compound, was developed to address the obstacles facing previous thiol-based drugs, their short half-live, and side effects and it's initial applications are for mitochondrial disease, Rett syndrome, and pediatric NASH.

Key Executives

NameTitle
Patrice RiouxCEO/Co-Founder/Co-President/Director
Brook G. RigginsCFO/Director/Secretary

More from The Globe